Prior ITP treatments most commonly prescribed to the participants were corticosteroids, intravenous immunoglobulin (IVIG), thrombopoietin receptor agonist (TPO-RA), and immunosuppressants. Here, TPO is linked to autoimmune thrombocytopenic purpura.